Sankala Group LLC

SEC CIK: 0002113426
Latest filing: Aug 18, 2026

SEC filings (opens in a new tab)

IMVT holding history

Immunovant, Inc. in every 13F filed by Sankala Group LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overview All 13F holders of IMVT Full Q2 2026 holdings

Shares (Q2 2026): 150
Value: $6.53K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of IMVT by Sankala Group LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	150	$6.53K	<0.1%	00.0%	Unchanged	Holders
Q1 2026	150	$3.71K	<0.1%	00.0%	Unchanged	Holders
Q4 2025	150	$4.16K	<0.1%	–	No prior filing	Holders